Marc’s aims for low prices
Cleveland, Ohio-based Marc’s will sell almost anything, provided it can price the item low and turn it quickly. But it won’t sell shrunken heads.
“We went to one customs auction a while ago and bought some artifacts,” said company founder Marc Glassman in a recent YouTube video. “Then we found out we’d bought some real shrunken heads from Peru. We were quite embarrassed.”
Heads aside, Glassman’s eccentric, eclectic retail brainchild is thriving — in part by defying retail norms. In an era of just-in-time logistics, the 60-store Marc’s chain — Glassman also owns five-store Xpect in Connecticut — doesn’t hesitate to buy multi-truckload quantities of deal and closeout merchandise to lock in a low price.
“With 60 stores, we have well over 1 million sq. ft. of warehouse, just to … bring stuff in,” Glassman said. “Some stuff we bring in six to eight months before the season, but if you’re buying closeouts — especially seasonal closeouts — you have to buy when it’s there.”
“We just want to turn products fast at the lowest prices,” Glassman said. “Literally no one in the country marks closeouts as low as we do.”
The discounts extend to the chain’s more than 50 pharmacies, with a $3.99 price point on more than 400 generic drugs and everyday low prices on diabetic supplies, blood-pressure monitors, digital thermometers, reading glasses, dietary supplements and more.
ReportersNotebook — Chain Pharmacy, 5/2/11
SUPPLIER NEWS — Hi-Tech Pharmacal announced the tentative approval by the Food and Drug Administration of levofloxacin oral solution in the 25-mg/mL strength, a generic antibiotic. Levofloxacin oral solution is a generic version of Johnson & Johnson’s Levaquin, which had sales of $6 million in 2010, according to IMS Health. Hi-Tech expected to receive final approval in June, when Johnson & Johnson’s patent expires.
The FDA has approved Horizant (gabapentin enacarbil), a drug made by GlaxoSmithKline and XenoPort, as a once-daily treatment for moderate-to-severe restless legs syndrome, the agency said.
The FDA announced the approval of AstraZeneca’s daily pill vandetanib for late-stage medullary thyroid cancer in patients whose disease is growing and causing symptoms, but who are ineligible for surgery, the agency said.
The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals’ single-pill antiretroviral for HIV-1 patients, BI said. Viramune XR (nevirapine) is a single-pill, once-daily, extended-release formulation of nevirapine for use in combination with other antiretroviral drugs.
Bartell benefits from HBW
Bartell Drugs, a family-owned regional chain since 1890, has still got it. The chain has brought together health and personal care by sponsoring health and beauty events, the first of which happened in October 2010 and featured health screenings, cosmetic demonstrations and hairstyling tips. Another event is scheduled for the fall.
Vaccinations have featured prominently in the chain’s business as well, with in-store flu vaccinations and corporate flu clinics for area businesses, as well as international travel clinics at 10 stores. In December 2010, the company donated 4,000 flu vaccine doses to support pharmacy outreach programs at the University of Washington and Washington State University, in Pullman, Wash., providing vaccinations to nonprofit groups and Native American tribal communities.